Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1

Interventions

relugolix 5Uterine Myomectomy 5Bupivacaine 4epigallocatechin gallate 2Vitamin D 2Vitamin B 6 2Sodium Chloride 2Observation 2Norethindrone Acetate 2Estradiol 2vilaprisan 1linzagolix 1elagolix 1Videotape Recording 1Uterine Artery Embolization 1Triamcinolone Acetonide 1Triamcinolone 1Therapeutics 1Tea 1Surveys and Questionnaires 1Standard of Care 1Simvastatin 1Saline Solution 1Robotic Surgical Procedures 1Restraint, Physical 1Radiofrequency Ablation 1Naproxen 1Morphine 1Methadone 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × linzagolix × 1 year × Clear all
NCT05445167 2025-11-25

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
89 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡